Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
precancerous conditions
MeSH D011230 - precancerous conditions
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009369:
Neoplasms
21 Companies
21 Drugs
$
Success rate
D011230:
Precancerous conditions
0 Companies
0 Drugs
Success rate
D000075122:
Smoldering multiple myeloma
0 Companies
0 Drugs
Success rate
D001471:
Barrett esophagus
1 Company
1 Drug
$
Success rate
D002578:
Uterine cervical dysplasia
2 Companies
0 Drugs
Success rate
D004919:
Erythroplasia
0 Companies
0 Drugs
Success rate
D007971:
Leukoplakia
0 Companies
0 Drugs
Success rate
D008230:
Lymphomatoid granulomatosis
1 Company
1 Drug
$
Success rate
D011289:
Preleukemia
0 Companies
0 Drugs
Success rate
D014983:
Xeroderma pigmentosum
0 Companies
0 Drugs
Success rate
D055623:
Actinic keratosis
16 Companies
4 Drugs
$
Success rate
D058739:
Aberrant crypt foci
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
64
%
30/47
Phase 2
23
%
13/56
Phase 3
0
%
0/22
Approved:
0
Overall Success rate:
0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use